您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览294 | 下载112

Rheumatoid arthritis ( RA ) has historically been a disabling and life-threatening disease, whose features include joint pain, stiffness and swelling, joint damage, fatigue, loss of function and loss of employment. RA not only erodes bones and joints, but also infringes organs. With recent advances in the treatment, particularly the use of conventional disease-modifying therapies earlier and in combination, and the advent of biological therapies, modern rheumatologists expect to help patient attain remission, with the advantages of early presentation and effective therapies used in the“treatment to target”strategy. Thus, the manifestations have changed a lot at present, and some serious complications have disappeared. Adherence to the guidance of American college of rheumatology ( ACR )/European league against rheumatism ( EULAR ), significant disease control and perhaps remission will be achieved, including early identification of the disease, early and aggressive use of disease-modifying antirheumatic

作者:赵云;张奉春

来源:中国骨与关节杂志 2013 年 7期

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:294 | 下载:112
作者:
赵云;张奉春
来源:
中国骨与关节杂志 2013 年 7期
标签:
Arthritis,rheumatoid Rheumatoid factor autoantibodies
Rheumatoid arthritis ( RA ) has historically been a disabling and life-threatening disease, whose features include joint pain, stiffness and swelling, joint damage, fatigue, loss of function and loss of employment. RA not only erodes bones and joints, but also infringes organs. With recent advances in the treatment, particularly the use of conventional disease-modifying therapies earlier and in combination, and the advent of biological therapies, modern rheumatologists expect to help patient attain remission, with the advantages of early presentation and effective therapies used in the“treatment to target”strategy. Thus, the manifestations have changed a lot at present, and some serious complications have disappeared. Adherence to the guidance of American college of rheumatology ( ACR )/European league against rheumatism ( EULAR ), significant disease control and perhaps remission will be achieved, including early identification of the disease, early and aggressive use of disease-modifying antirheumatic